TFC Financial Management Inc. Boosts Position in CME Group Inc. (NASDAQ:CME)

TFC Financial Management Inc. lifted its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 8.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 592 shares of the financial services provider’s stock after acquiring an additional 46 shares during the period. TFC Financial Management Inc.’s holdings in CME Group were worth $137,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. Truvestments Capital LLC purchased a new stake in CME Group in the 3rd quarter valued at about $26,000. SJS Investment Consulting Inc. raised its holdings in CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after buying an additional 97 shares during the period. Dunhill Financial LLC raised its holdings in CME Group by 188.4% in the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after buying an additional 81 shares during the period. Financial Life Planners purchased a new stake in CME Group in the 4th quarter valued at about $32,000. Finally, Fortitude Family Office LLC raised its holdings in CME Group by 120.3% in the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after buying an additional 83 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME opened at $248.96 on Thursday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The firm has a market cap of $89.72 billion, a PE ratio of 26.18, a price-to-earnings-growth ratio of 5.54 and a beta of 0.57. The company’s 50 day simple moving average is $235.62 and its 200-day simple moving average is $224.91. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $253.53.

CME Group (NASDAQ:CMEGet Free Report) last announced its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.46 by $0.06. CME Group had a net margin of 57.34% and a return on equity of 13.39%. As a group, equities analysts predict that CME Group Inc. will post 10.18 EPS for the current year.

CME Group announced that its Board of Directors has authorized a stock buyback program on Thursday, December 5th that authorizes the company to buyback $3.00 billion in shares. This buyback authorization authorizes the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s board of directors believes its shares are undervalued.

CME Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Friday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 dividend on an annualized basis and a dividend yield of 2.01%. CME Group’s dividend payout ratio (DPR) is 48.37%.

Analyst Ratings Changes

Several brokerages recently issued reports on CME. Oppenheimer boosted their price objective on shares of CME Group from $245.00 to $258.00 and gave the company an “outperform” rating in a report on Thursday, October 24th. Royal Bank of Canada reissued a “sector perform” rating and set a $235.00 price target on shares of CME Group in a research report on Monday, January 6th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Barclays increased their price target on shares of CME Group from $231.00 to $257.00 and gave the stock an “equal weight” rating in a research report on Monday, December 9th. Finally, Citigroup cut shares of CME Group from a “buy” rating to a “neutral” rating and reduced their price target for the stock from $255.00 to $250.00 in a research report on Monday, January 6th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, CME Group has a consensus rating of “Hold” and an average target price of $229.27.

Check Out Our Latest Stock Analysis on CME

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.